Stephen J. Schueler, M.D.

Overview Incidence Risk Factors Symptoms Evaluation Treatment questions for doctor specialist Home Care diet warning signs Prevention Outlook Complications Underlying Cause Transmission Types Anatomy

Infected Liver Viral Questions For Doctor

The following are some important questions to ask before and after the treatment of viral hepatitis.

Questions to ask before treatment:

  • What are my treatment options?
  • What are the risks associated with treatment?
  • Do I need to stay in the hospital?
    • How long will I be in the hospital?
  • Am I contagious?
    • For how long?
  • What are the complications I should watch for?
  • How do I avoid passing the infection to others?
  • How long will I be on medication?
  • What are the potential side effects of my medication?
  • Does my medication interact with nonprescription medicines or supplements?
  • Should I take my medication with food?

Questions to ask after treatment:
  • Do I need to change my diet?
  • Are there any medications or supplements I should avoid?
  • When can I resume my normal activities?
  • When can I return to work?
  • What else can I do to reduce my risk for complications of viral hepatitis?
  • How often will I need to see my doctor for checkups?
  • What local support and other resources are available?

Continue to Infected Liver Viral Specialist

Last Updated: Jul 15, 2009 References
Authors: Stephen J. Schueler, MD; John H. Beckett, MD; D. Scott Gettings, MD
Copyright DSHI Systems, Inc. Powered by: FreeMD - Your Virtual Doctor

PubMed Infected Liver Viral References
  1. Bianco E, De Masi S, Mele A, Jefferson T. Effectiveness of immune globulins in preventing infectious hepatitis and hepatitis A: a systematic review. Dig Liver Dis. 2004 Dec;36(12):834-42. [1564643]
  2. Ferenci P. Treatment of chronic viral hepatitis. Best Pract Res Clin Gastroenterol. 2004;18 Suppl:113-20. [15588803]
  3. Kanwal F, Gralnek IM, Martin P, Dulai GS, Farid M, Spiegel BM. Treatment alternatives for chronic hepatitis B virus infection: a cost-effectiveness analysis. Ann Intern Med. 2005 May 17;142(10):821-31. [1589753]
  4. Kim AI, Saab S. Treatment of hepatitis C. Am J Med. 2005 Aug;118(8):808-15. [16084169]
  5. Oncu S, Oncu S, Sakarya S. Hepatitis A and B seropositivity among medical students. Health Policy. 2005 Sep 28;74(1):39-45. [16098410]
  6. Wasley A, Samandari T, Bell BP. Incidence of hepatitis A in the United States in the era of vaccination. JAMA. 2005 Jul 13;294(2):194-201. [1601459]
FreeMD is provided for information purposes only and should not be used as a substitute for evaluation and treatment by a physician. Please review our terms of use.